Literature DB >> 11568656

Nociceptin-induced internalization of the ORL1 receptor in human neuroblastoma cells.

S Spampinato1, R Di Toro, A R Qasem.   

Abstract

Nociceptin/orphanin FQ (NC) has been proposed as endogenous ligand of the opioid receptor-like 1 (ORL1) receptor. We investigated NC-induced internalization and recycling of the ORL1 receptor in SK-N-BE human neuroblastoma cells. Internalization was proven by receptor binding assay on viable cells. NC promotes a time- and concentration-dependent internalization of the ORL1 receptor (57% of cell surface receptors are lost after 30 min exposure to 1 microM NC) in a clathrin- and ATP- dependent manner. After 30 min exposure to NC, ORL1 receptor internalization is partially reversible and recycling is dependent on acid phosphatases. Over-expression of beta-arrestin 2 increases NC-promoted internalization of the ORL1 receptor. These events contribute to NC signaling in neuronal cells through sequestration and recycling of the ORL1 receptor.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11568656     DOI: 10.1097/00001756-200110080-00035

Source DB:  PubMed          Journal:  Neuroreport        ISSN: 0959-4965            Impact factor:   1.837


  11 in total

1.  Arrestin 3 mediates endocytosis of CCR7 following ligation of CCL19 but not CCL21.

Authors:  Melissa A Byers; Psachal A Calloway; Laurie Shannon; Heather D Cunningham; Sarah Smith; Fang Li; Brian C Fassold; Charlotte M Vines
Journal:  J Immunol       Date:  2008-10-01       Impact factor: 5.422

Review 2.  Functional plasticity of the N/OFQ-NOP receptor system determines analgesic properties of NOP receptor agonists.

Authors:  W Schröder; D G Lambert; M C Ko; T Koch
Journal:  Br J Pharmacol       Date:  2014-08       Impact factor: 8.739

3.  Opioid-related (ORL1) receptors are enriched in a subpopulation of sensory neurons and prolonged activation produces no functional loss of surface N-type calcium channels.

Authors:  Swetha S Murali; Ian A Napier; Beth K Rycroft; MacDonald J Christie
Journal:  J Physiol       Date:  2012-02-27       Impact factor: 5.182

4.  Low utility of plasma Nociceptin/orphanin FQ in the diagnosis of hepatocellular carcinoma.

Authors:  Aldo Spadaro; Antonino Ajello; Carmelo Luigiano; Carmela Morace; Maria Letizia Resta; Grazia Berlinghieri; Salvatore Campo; Claudio Scisca; Angela Alibrandi; Graziella D'Arrigo; Nunziata Alessi; Oscar Ferrau; Maria Antonietta Freni
Journal:  World J Gastroenterol       Date:  2006-08-07       Impact factor: 5.742

Review 5.  Molecular mechanisms of opioid receptor-dependent signaling and behavior.

Authors:  Ream Al-Hasani; Michael R Bruchas
Journal:  Anesthesiology       Date:  2011-12       Impact factor: 7.892

Review 6.  Nociceptin/Orphanin FQ Receptor Structure, Signaling, Ligands, Functions, and Interactions with Opioid Systems.

Authors:  Lawrence Toll; Michael R Bruchas; Girolamo Calo'; Brian M Cox; Nurulain T Zaveri
Journal:  Pharmacol Rev       Date:  2016-03-08       Impact factor: 25.468

7.  Effects of receptor density on Nociceptin/OrphaninFQ peptide receptor desensitisation: studies using the ecdysone inducible expression system.

Authors:  T A Barnes; J McDonald; D J Rowbotham; T L Duarte; D G Lambert
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2007-09-25       Impact factor: 3.000

Review 8.  Cellular mechanisms of nociceptin/orphanin FQ (N/OFQ) peptide (NOP) receptor regulation and heterologous regulation by N/OFQ.

Authors:  Courtney L Donica; Hibah O Awwad; Deepak R Thakker; Kelly M Standifer
Journal:  Mol Pharmacol       Date:  2013-02-08       Impact factor: 4.436

9.  Increased nociceptin/orphanin FQ plasma levels in hepatocellular carcinoma.

Authors:  Ferenc Szalay; Monika B Hantos; Andrea Horvath; Peter L Lakatos; Aniko Folhoffer; Kinga Dunkel; Dalma Hegedus; Kornelia Tekes
Journal:  World J Gastroenterol       Date:  2004-01       Impact factor: 5.742

Review 10.  Role of nociceptin/orphanin FQ and nociceptin opioid peptide receptor in depression and antidepressant effects of nociceptin opioid peptide receptor antagonists.

Authors:  Jong Yung Park; Suji Chae; Chang Seop Kim; Yoon Jae Kim; Hyun Joo Yi; Eunjoo Han; Youngshin Joo; Surim Hong; Jae Won Yun; Hyojung Kim; Kyung Ho Shin
Journal:  Korean J Physiol Pharmacol       Date:  2019-10-24       Impact factor: 2.016

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.